Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Alto Neuroscience, Inc. Market Cap
Based on ratings from 6 stock analysts, the Alto Neuroscience, Inc. stock price is expected to increase by 184.54% in 12 months. This is calculated by using the average 12-month stock price forecast for Alto Neuroscience, Inc.. The lowest target is $4 and the highest is $17. Please note analyst price targets are not guaranteed and could be missed completely.
About 6 Wall Street analysts have assignedANRO 5 buy ratings, 1 hold ratings, and 0 sell ratings. This means that analysts expect Alto Neuroscience, Inc. to buy. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on ANRO. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of ANRO.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| Paul Matteis Stifel | Buy | $10 | Maintains | Nov 13, 2024 |
| Brian Skorney Baird | Outperform | $10 | Maintains | Oct 23, 2024 |
| Laura Chico Wedbush | Neutral | $4 | Downgrade | Oct 23, 2024 |
| Laura Chico Wedbush | Outperform | $29 | Reiterates | Sep 10, 2024 |
| Laura Chico Wedbush | Outperform | $29 | Initiates | Sep 3, 2024 |
| Elemer Piros Rodman & Renshaw | Buy | $43 | Initiates | Jun 21, 2024 |
| Paul Matteis Stifel | Buy | $32 | Reiterates | Mar 25, 2024 |
| Brian Skorney Baird | Outperform | $32 | Initiates | Feb 27, 2024 |
| Paul Matteis Stifel | Buy | $32 | Initiates | Feb 27, 2024 |
| Andrew Tsai Jefferies | Buy | $33 | Initiates | Feb 27, 2024 |
When did it IPO
N/A
Staff Count
78
Country
United States
Sector/Industry
Healthcare/Biotechnology
CEO
Dr. Amit Etkin M.D., Ph.D.
Market Cap
$105.5M
In 2023, ANRO generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that ANRO's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Sat, 07 Dec 2024
Sentiment - NEUTRAL
Source - Accesswire
Summary - The Schall Law Firm is investigating Alto Neuroscience (NYSE:ANRO) for potential securities law violations, including false statements affecting investors.
Why It Matters - Investigation into Alto Neuroscience for potential securities law violations may indicate risks of financial loss, affecting stock performance and investor confidence in the company.
Sun, 08 Dec 2024
Sentiment - NEUTRAL
Source - Accesswire
Summary - The Schall Law Firm is investigating Alto Neuroscience, Inc. (NYSE:ANRO) for possible securities law violations, including false statements and undisclosed information affecting investors.
Why It Matters - Alto Neuroscience faces a legal investigation for potential securities law violations, which could impact stock value, investor confidence, and market perception.
Mon, 09 Dec 2024
Sentiment - NEUTRAL
Source - Accesswire
Summary - The Schall Law Firm is investigating Alto Neuroscience, Inc. (NYSE:ANRO) for possible securities law violations, including misleading statements affecting investors.
Why It Matters - Alto Neuroscience faces legal scrutiny for potential securities law violations, which could impact its stock value and investor confidence, signaling increased risk for shareholders.
Wed, 04 Dec 2024
Sentiment - NEUTRAL
Source - Accesswire
Summary - The Schall Law Firm is investigating Alto Neuroscience (NYSE:ANRO) for potential securities law violations related to misleading statements and undisclosed information affecting investors.
Why It Matters - The investigation into Alto Neuroscience for potential securities law violations may signal underlying issues, affecting investor confidence and the stock's performance.
Thu, 05 Dec 2024
Sentiment - NEUTRAL
Source - Accesswire
Summary - The Schall Law Firm is investigating Alto Neuroscience, Inc. (NYSE: ANRO) for potential securities law violations, including possible false or misleading statements to investors.
Why It Matters - Alto Neuroscience faces legal scrutiny over potential securities law violations, which could impact stock value and investor confidence in the company.
Fri, 06 Dec 2024
Sentiment - NEUTRAL
Source - Accesswire
Summary - The Schall Law Firm is investigating Alto Neuroscience (NYSE:ANRO) for potential securities law violations, including false statements or undisclosed information affecting investors.
Why It Matters - The investigation into Alto Neuroscience for potential securities law violations could signal legal risks and affect stock performance, impacting investor confidence and share prices.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
